MedElevator
Войти в исследования The Australian & New Zealand journal of obstetrics & gynaecology · 2025
Trends in the Use and Indications for Intracytoplasmic Sperm Injection Between 2005 and 2017: A State-Wide Descriptive Cohort Analysis.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kink Aleah, Mehdipour Parinaz, Hiscock Richard J, Vollenhoven Beverley J, Stern Catharyn J, Walker Susan P, Green Mark P, Osianlis Tiki, Agresta Franca, Wilkinson David, Tong Stephen, Hastie Roxanne, Kennedy Amber L, Lindquist Anthea C
Аннотация
BACKGROUND: Intracytoplasmic sperm injection (ICSI) was first developed to overcome male factor infertility. ICSI has increased in uptake globally, including in cases where its use is non-essential for fertilisation.
AIMS: To identify temporal trends in the use of, and indications for ICSI in an Australian context.
MATERIALS AND METHODS: A statewide descriptive cohort study examining the trends in ICSI uptake and reported indication/s for ICSI use. The cohort included women undergoing IVF between 2005 and 2017 at IVF clinics across Victoria, Australia that resulted in a birth after 20 weeks' gestation.
RESULTS: The dataset comprised 32 102 assisted reproduction cycles: 22 873 (71.3%) ICSI and 9229 (28.7%) conventional IVF. In 2005, ICSI accounted for 60.6% (1182/1952) of cycles, increasing to 79.5% (2344/2947) by 2017 (ptrend < 0.001). Testicular sperm retrieval as an indication for ICSI remained consistent over time (ptrend = 0.15). Male factor infertility as an indication decreased over time (ptrend = 0.007). Vitrified oocyte thaw (ptrend = 0.016) and 'unexplained subfertility' (ptrend = 0.30) cycles did not surpass 1.7% (39/2293) and 0.4% (9/2048), respectively of total cycles in any year. Donor sperm (ptrend = 0.001), pre-implantation genetic testing (ptrend = 0.004), female factors associated with poor IVF outcome (ptrend = 0.005) and advanced maternal age (ptrend = 0.005) all increased as indications for ICSI over time. 'Unspecified' indication accounted for the majority of ICSI cycles after 2008 (ptrend = 0.015).
CONCLUSIONS: During our study period, the total use of ICSI increased by 18.9%. Notably, most of these cycles were not medically indicated.
AIMS: To identify temporal trends in the use of, and indications for ICSI in an Australian context.
MATERIALS AND METHODS: A statewide descriptive cohort study examining the trends in ICSI uptake and reported indication/s for ICSI use. The cohort included women undergoing IVF between 2005 and 2017 at IVF clinics across Victoria, Australia that resulted in a birth after 20 weeks' gestation.
RESULTS: The dataset comprised 32 102 assisted reproduction cycles: 22 873 (71.3%) ICSI and 9229 (28.7%) conventional IVF. In 2005, ICSI accounted for 60.6% (1182/1952) of cycles, increasing to 79.5% (2344/2947) by 2017 (ptrend < 0.001). Testicular sperm retrieval as an indication for ICSI remained consistent over time (ptrend = 0.15). Male factor infertility as an indication decreased over time (ptrend = 0.007). Vitrified oocyte thaw (ptrend = 0.016) and 'unexplained subfertility' (ptrend = 0.30) cycles did not surpass 1.7% (39/2293) and 0.4% (9/2048), respectively of total cycles in any year. Donor sperm (ptrend = 0.001), pre-implantation genetic testing (ptrend = 0.004), female factors associated with poor IVF outcome (ptrend = 0.005) and advanced maternal age (ptrend = 0.005) all increased as indications for ICSI over time. 'Unspecified' indication accounted for the majority of ICSI cycles after 2008 (ptrend = 0.015).
CONCLUSIONS: During our study period, the total use of ICSI increased by 18.9%. Notably, most of these cycles were not medically indicated.